Concepedia

Anne Hawdon

AH

Statistics

Publications

3

Citations

399

H-Index

3

Active since

2006

Affiliations

Eli Lilly (Singapore)(Current)

Eli Lilly (United Kingdom)

Eli Lilly (United States)

Anne Hawdon is an author at Eli Lilly (Singapore) specializing in pharmacology, alzheimer disease, and medicine.

Publications per year

2006–2021

3

Publications

3

Factors Affecting the Bioavailability of Soy Isoflavones in Humans after Ingestion of Physiologically Relevant Levels from Different Soy Foods

Aedín Cassidy, Jonathan E. Brown, Anne Hawdon et al. · Journal of Nutrition · 2006 · 255 citations

Pharmacy, Nutritional Sciences, Pharmacokinetics +9

Donanemab (LY3002813) dose‐escalation study in Alzheimer's disease

Stephen L. Lowe, Brian A. Willis, Anne Hawdon et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2021 · 120 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

O4‐08‐06: SAFETY, PHARMACOKINETICS (PK), AND FLORBETAPIR F‐18 POSITRON EMISSION TOMOGRAPHY (PET) AFTER MULTIPLE DOSE ADMINISTRATION OF LY3002813, A β‐AMYLOID PLAQUE‐SPECIFIC ANTIBODY, IN ALZHEIMER’S DISEASE (AD)

Michael C. Irizarry, John R. Sims, Stephen L. Lowe et al. · Alzheimer s & Dementia · 2016 · 24 citations

Medicine, Neurology, Pharmacology +17

1–3 of 3